Skip to main content
Retour
Watch Compare

Fulcrum Therapeutics, Inc.

Qualité des données : 83%
FULC
Nasdaq Manufacturing Chemicals
7,55 €
▼ 0,36 € (-4,55%)
Cap. Boursière: 526,81 M
Prix
7,91 €
Cap. Boursière
526,81 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -60,38 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-36,28%
Au-dessus de la moyenne du secteur (-53,34%)
ROIC-31,66%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio17,70
Interest CoverageN/A

Valorisation

PE (TTM)
-7,04
En dessous de la moyenne du secteur (-1,47)
P/B Ratio2,66
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -7,0 -1,5
P/B 2,7 1,6
ROE % -36,3 -53,3
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Objectif de Cours des Analystes

10 analystes
Buy
Actuel
7,55 €
+151.7%
Objectif
19,00 €
7,00 €
21,50 €
25,00 €
Prévisions
P/E Prévisionnel -4,71
BPA Prévisionnel -1,60 €
CA Est. 0,0

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 -1,60 €
-2,11 € – -1,08 €
 0,0 10
FY2026 -1,30 €
-1,70 € – -1,04 €
 0,0 11

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42025 -0,30 € -0,31 € -2,3%
Q32025 -0,29 € -0,31 € -5,5%
Q22025 -0,29 € -0,28 € +3,5%
Q12025 -0,33 € -0,28 € +13,9%

ETFs Holding This Stock

PINK logo PINK Simplify Health Care ETF
0,39% weight
NOSGX NOSGX
0,27% weight
BRSIX BRSIX
0,26% weight
GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0,08% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0,05% weight
CSGEX CSGEX
0,03% weight
PSGIX PSGIX
0,03% weight
BDSCX BDSCX
0,03% weight
BDSAX BDSAX
0,03% weight
BDSIX BDSIX
0,03% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -74,88 M
ROE -36,28% ROA -33,75%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -60,38 M
ROIC -31,66% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 17,70
Interest Coverage N/A Asset Turnover N/A
Working Capital 194,23 M Tangible Book Value 198,37 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -7,04 Forward P/E N/A
P/B Ratio 2,66 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -11,46%
Market Cap 526,81 M Enterprise Value 479,73 M
Per Share
EPS (Diluted TTM) -1,18 Revenue / Share N/A
FCF / Share -0,91 OCF / Share -0,90
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 80,63%
SBC-Adj. FCF -73,70 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -74,88 M -9,73 M -97,34 M -109,87 M -80,85 M
EPS (Diluted) -1,18 -0,16 -1,59 -2,44 -2,29
Gross Profit — — — — —
Operating Income -84,77 M -21,90 M -110,66 M -112,56 M -81,05 M
EBITDA — — — — —
R&D Expenses 56,10 M 63,39 M 71,80 M 76,78 M 69,70 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — —
Income Tax 0,0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 366,28 M 260,72 M 257,69 M 226,69 M 235,00 M
Total Liabilities 17,28 M 17,68 M 22,50 M 27,74 M 23,46 M
Shareholders' Equity 349,00 M 243,03 M 235,19 M 198,94 M 211,54 M
Total Debt — — — — —
Cash & Equivalents 197,53 M 58,21 M 25,56 M 35,10 M 35,41 M
Current Assets 357,48 M 249,92 M 242,20 M 207,52 M 226,00 M
Current Liabilities 13,05 M 11,04 M 13,68 M 16,73 M 19,20 M